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Abstract
Biology has changed radically in the last two decades, transitioning from a de-
scriptive science into a design science. Synthetic biology allows us to bioengineer
cells to synthesize novel valuable molecules such as renewable biofuels or anticancer
drugs. However, traditional synthetic biology approaches involve ad-hoc non system-
atic engineering practices, which lead to long development times. Here, we present the
Automated Recommendation Tool (ART), a tool that leverages machine learning and
probabilistic modeling techniques to guide synthetic biology in a systematic fashion,
without the need for a full mechanistic understanding of the biological system. Using
sampling-based optimization, ART provides a set of recommended strains to be built in
the next engineering cycle, alongside probabilistic predictions of their production levels.
We demonstrate the capabilities of ART on simulated and real data sets and discuss
possible difficulties in achieving satisfactory predictive power.
2
Introduction
Metabolic engineering1 enables us to bioengineer cells to synthesize novel valuable molecules
such as renewable biofuels2,3 or anticancer drugs.4 The prospects of metabolic engineering
to have a positive impact in society are on the rise, as it was considered one of the “Top Ten
Emerging Technologies” by the World Economic Forum in 2016.5 Furthermore, an incoming
industrialized biology is expected to improve most human activities: from creating renewable
bioproducts and materials, to improving crops and enabling new biomedical applications.6
However, the practice of metabolic engineering has been far from systematic, which has
significantly hindered its overall impact.7 Metabolic engineering has remained a collection
of useful demonstrations rather than a systematic practice based on generalizable methods.
This limitation has resulted in very long development times: for example, it took 150 person-
years of effort to produce the antimalarial precursor artemisinin by Amyris; and 575 person-
years of effort for Dupont to generate propanediol,8 which is the base for their commercially
available Sorona fabric.9
Synthetic biology10 aims to improve genetic and metabolic engineering by applying sys-
tematic engineering principles to achieve a previously specified goal. Synthetic biology en-
compasses, and goes beyond, metabolic engineering: it also involves non-metabolic tasks
such as, e.g., gene drives able to estinguish malaria-bearing mosquitoes11 or engineering
microbiomes to replace fertilizers.12 This discipline is enjoying an exponential growth, as it
heavily benefits from the byproducts of the genomic revolution: high-throughput multi-omics
phenotyping,13,14 accelerating DNA sequencing15 and synthesis capabilities,16 and CRISPR-
enabled genetic editing.17 This exponential growth is reflected in the private investment
in the field, which has totalled ∼$12B in the 2009-2018 period and is rapidly accelerating
(∼$2B in 2017 to ∼$4B in 2018).18
One of the synthetic biology engineering principles used to improve metabolic engineering
is the Design-Build-Test-Learn (DBTL19,20) cycle: a loop used recursively to obtain a design
that satisfies the desired specifications (e.g. a particular titer, rate, yield or product). The
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DBTL cycle’s first step is to design (D) a biological system expected to meet the desired
outcome. That design is built (B) in the next phase from DNA parts into an appropriate mi-
crobial chassis using synthetic biology tools. The next phase involves testing (T) whether the
built biological system indeed works as desired in the original design, via a variety of assays:
e.g. measurement of production or/and ‘omics (transcriptomics, proteomics, metabolomics)
data profiling. It is extremely rare that the first design behaves as desired, and further at-
tempts are typically needed to meet the desired specification. The Learn (L) step leverages
the data previously generated to inform the next Design step so as to converge to the desired
specification faster than through a random search process.
The Learn phase of the DBTL cycle has traditionally been the most weakly supported
and developed,20 despite its critical importance to accelerate the full cycle. The reasons
are multiple, although their relative importance is not entirely clear. Arguably, the main
drivers of the lack of emphasis on the L phase are: the lack of predictive power for biological
systems behavior,21 the reproducibility problems plaguing biological experiments,3,22–24 and
the traditionally limited emphasis on mathematical training for synthetic biologists.
Machine learning (ML) arises as an effective tool to predict biological system behavior
and empower the Learn phase, enabled by emerging high-throughput phenotyping technolo-
gies.25 Machine Learning has been used to produce driverless cars,26 automate language
translation,27 predict sexual orientation from Facebook profiles,28 predict pathway dynam-
ics,29 optimize pathways through translational control,30 diagnose skin cancer,31 detect tu-
mors in breast tissues,32 and predict DNA and RNA protein-binding sequences,33 drug side
effects34 and antibiotic mechanisms of action.35 However, the practice of machine learning
requires statistical and mathematical expertise that is scarce, and highly competed for in
other fields.36
Here, we provide a tool that leverages machine learning for synthetic biology’s purposes:
the Automated Recommendation Tool (ART).ART combines the widely-used and general-
purpose open source scikit-learn library37 with a novel Bayesian ensemble approach, in a
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manner that adapts to the particular needs of synthetic biology projects: e.g. low number
of conditions, recursive DBTL cycles, and the need for uncertainty quantification. The data
sets collected in the synthetic biology field are typically not large enough to allow for the
use of deep learning (< 100 conditions), but our ensemble model will be able to integrate
this approach when high-throughput data generation14,38 and automated data collection39
become widely used in the future. ART provides machine learning capabilities in an easy-
to-use and intuitive manner, and is able to guide synthetic biology efforts in an effective
way.
We showcase the efficacy of ART in guiding synthetic biology through four different ex-
amples: a test case with simulated data and three real cases of metabolic engineering. The
test case permits us to explore how the machine learning algorithms perform when applied
to systems that present different levels of difficulty when being “learnt”, as well as the effec-
tiveness of using several DTBL cycles. The real metabolic engineering cases involve data sets
from published metabolic engineering projects: renewable biofuel production, yeast bioengi-
neering to recreate the flavor of hops in beer, and fatty alcohols synthesis. These projects
illustrate what to expect under different typical metabolic engineering situations: high/low
coupling of the heterologous pathway to host metabolism, complex/simple pathways, high-
/low number of conditions, high/low difficulty in learning pathway behavior.
In sum, ART provides a tool specifically tailored to the synthetic biologist’s needs in order
to leverage the power of machine learning to enable predictable biology. This combination of
synthetic biology with machine learning and automation has the potential to revolutionize
bioengineering25 by enabling effective inverse design. This paper is written so as to be
accessible to both the machine learning and synthetic biology readership, with the intention
of providing a much needed bridge between these two very different collectives. Hence, we
apologize if we put excessive emphasis on explaining basic machine learning or synthetic
biology concepts: they will surely be of use to a part of the readership.
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Methods
Key capabilities
ART leverages machine learning to improve the efficacy of bioengineering microbial strains
for the production of desired bioproducts (Fig. 1). ART gets trained on available data to
produce a model capable of predicting the response variable (e.g. final production of the jet
fuel limonene) from the input data (e.g. proteomics data, or any other type of data that can
be expressed as a vector). Furthermore, ART uses this model to recommend new inputs (e.g.
proteomics profiles) that are predicted to reach our desired goal (e.g. improve production).
As such, ART bridges the Learn and Design phases of a DBTL cycle.
Figure 1: ART overview. ART uses experimental data to i) build a probabilistic predictive
model that predicts output (e.g. production) from input variables (e.g. proteomics), and ii)
uses this model to provide a set of recommended designs for the next experiment, along with
the probabilistic predictions of the response.
ART can import data directly from Experimental Data Depot,40 an online tool where
experimental data and metadata are stored in a standardized manner. Alternatively, ART
can import EDD-style .csv files, which use the nomenclature and structure of EDD exported
files.
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By training on the provided data set, ART builds a predictive model for the response as a
function of the input variables. Rather than predicting point estimates of the output variable,
ART provides the full probability distribution of the predictions. This rigorous quantification
of uncertainty enables a principled way to test hypothetical scenarios in-silico, and to guide
design of experiments in the next DBTL cycle. The Bayesian framework chosen to provide
the uncertainty quantification is particularly tailored to the type of problems most often
encountered in metabolic engineering: sparse data which is expensive and time consuming
to generate.
With a predictive model at hand, ART can provide a set of recommendations expected
to produce a desired outcome, as well as probabilistic predictions of the associated response.
ART supports the following typical metabolic engineering objectives: maximization of the
production of a target molecule (e.g. to increase Titer, Rate and Yield, TRY), its minimiza-
tion (e.g. to decrease the toxicity), as well as specification objectives (e.g. to reach specific
level of a target molecule for a desired beer taste profile). Furthermore, ART leverages the
probabilistic model to estimate the probability that at least one of the provided recommen-
dations is successful (e.g. it improves the best production obtained so far), and derives how
many strain constructions would be required for a reasonable chance to achieve the desired
goal.
While ART can be applied to problems with multiple output variables of interest, it
currently supports only the same type of objective for all output variables. Hence, it does
not support maximization of one target molecule along with minimization of another.
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Mathematical methodology
Learning from data: a predictive model through machine learning and a novel
Bayesian ensemble approach
By learning the underlying regularities in experimental data, machine learning can provide
predictions without a detailed mechanistic understanding (Fig. 2). Training data is used to
statistically link an input (i.e. features or independent variables) to an output (i.e. response
or dependent variables) through models that are expressive enough to represent almost any
relationship. After this training, the models can be used to predict the outputs for inputs
that the model has never seen before.
Figure 2: ART provides a probabilistic predictive model of the response (e.g.
production). ART combines several machine learning models from the scikit-learn library
with a novel Bayesian approach to predict the probability distribution of the output. The
input to ART is proteomics data (or any other input data in vector format: transcriptomics,
gene copy, etc.), which we call level-0 data. This level-0 data is used as input for a variety
of machine learning models from the sci-kit learn library (level-0 learners) that produce a
prediction of production for each model (zi). These predictions (level-1 data) are used as
input for the Bayesian ensemble model (level-1 learner), which weights these predictions
differently depending on the ability of the Bayesian ensemble model to predict the training
data. The weights wi and the variance σ are characterized through probability distributions,
giving rise to a final prediction in the form of a full probability distribution of response levels.
Model selection is a significant challenge in machine learning, since there is a large variety
of models available for learning the relationship between response and input, but none of
them is optimal for all learning tasks.41 Furthermore, each model features hyperparameters
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(i.e. parameters that are set before the training process) that crucially affect the quality of
the predictions (e.g. number of trees for random forest or degree of polynomials in polynomial
regression), and finding their optimal values is not trivial.
We have sidestepped the challenge of model selection by using an ensemble model ap-
proach. This approach takes the input of various different models and has them “vote” for a
particular prediction. Each of the ensemble members is trained to perform the same task and
their predictions are combined to achieve an improved performance. The ensemble model
can be a set of different models (heterogeneous case) or the same models with different pa-
rameters (homogeneous case). The examples of the random forest42 or the super learner
algorithm43 have shown that simple models can be significantly improved by using a set of
them (e.g. several types of decision trees in a random forest algorithm). We have chosen a
heterogeneous ensemble learning approach that uses reasonable hyperparameters for each of
the model types.
ART uses a novel probabilistic ensemble approach where the weight of each ensemble
model is considered a random variable, with a probability distribution constrained by the
available data. Unlike other approaches,44–47 this method does not require the ensemble
models to be probabilistic in nature, hence allowing us to fully exploit the popular scikit-
learn library to increase accuracy by leveraging a diverse set of models (see "Related work
and novelty of our ensemble approach" in supp. material). This weighted ensemble model
approach produces a simple, yet powerful, way to quantify uncertainty, a critical capability
when dealing with small data sets and a crucial component of AI in biological research.48
Here we describe our approach for the single response variable problems, whereas the multiple
variables case can be found in the "Multiple response variables" section in the supplementary
material. Using a common notation in ensemble modeling we define the following levels of
data and learners (see Fig. 2):
• Level-0 data (D) represent the historical data consisting of N known inputs and re-
sponses, i.e. D = {(xn, yn), n = 1, . . . , N}, where x ∈ X ⊆ RD are the features
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(input) and y ∈ R is the associated response variable. For the sake of cross-validation,
the level-0 data are further divided into validation (D(k)) and training sets (D(−k)).
D(k) ⊂ D is the kth fold of a K-fold cross-validation obtained by randomly splitting
the set D into K almost equal parts; and D(−k) = D \ D(k) is the set D without the
kth fold D(k). Note that these sets do not overlap and cover the full available data:
i.e. D(ki) ∩ D(kj) = ∅, i 6= j and ∪iD(ki) = D.
• Level-0 learners (fm) consist of M base learning algorithms fm,m = 1, . . . ,M used to
learn from level-0 training data D(−k). For ART, we have chosen the following eight
algorithms from the scikit-learn library: Random Forest, Neural Network, Support
Vector Regressor, Kernel Ridge Regressor, K-NN Regressor, Gaussian Process Regres-
sor, Gradient Boosting Regressor, as well as TPOT (tree-based pipeline optimization
tool49). TPOT uses genetic algorithms to find the combination of the 11 different
regressors and 18 different preprocessing algorithms from scikit-learn that, properly
tuned, provides the best the cross-validated performance on the training set.
• Level-1 data (DCV ) are data derived from D by leveraging cross-validated predictions
of the level-0 learners. More specifically, level-1 data are given by the set DCV =
{(zn, yn), n = 1, . . . , N}, where zn = (z1n . . . , zMn) are predictions for level-0 data
(xn ∈ D(k)) of level-0 learners (f (−k)m ) trained on observations which are not in fold k
(D(−k)): zmn = f (−k)m (xn),m = 1, . . . ,M .
• The level-1 learner (F ), or metalearner, is a linear weighted combination of level-0
learners, with weights wm, m = 1, . . . ,M being random variables that are non-negative
and normalized to one. Each wm can be interpreted as the relative confidence in model
m. Hence, given an input x the response variable y is modeled as:
F : y = wT f(x) + ε, ε ∼ N (0, σ2), (1)
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where w = [w1 . . . wM ]T is the vector of weights such that
∑
wm = 1, wm ≥ 0, f(x) =
[f1(x) . . . fM(x)]
T is the vector of level-0 learners, and ε is a normally distributed
error variable with a zero mean and standard deviation σ. The constraint
∑
wm = 1
(i.e. that the ensemble is a convex combination of the base learners) is empirically
motivated but also supported by theoretical considerations.50 We denote the unknown
ensemble model parameters as θ ≡ (w, σ), constituted of the vector of weights and
the Gaussian error standard deviation. These parameters θ are obtained by training
F on the level-1 data DCV only. However, the final model F to be used for generating
predictions for new inputs uses θ inferred from level-1 data DCV , and the base learners
fm,m = 1, . . . ,M trained on the full original data set D, rather than only on the
level-0 data partitions D(−k). This follows the usual procedure in developing ensemble
learners51,52 in the context of stacking.50
Rather than providing a single estimate of ensemble model parameters θ that best fit
the training data, a Bayesian model provides a joint probability distribution p(θ|D) which
quantifies the probability that a given set of parameters explains the training data. This
Bayesian approach makes it possible to (i) make inferences about new observations, and
(ii) examine the uncertainty in the model. Model parameters θ are characterized by full
posterior distribution p(θ|D) that is inferred from level-1 data. Since this distribution is
analytically intractable, we sample from it using the Markov Chain Monte Carlo (MCMC)
technique,53 which samples the parameter space with a frequency proportional to the desired
posterior p(θ|D) (See "Markov Chain Monte Carlo sampling" section in Supp. Material).
As a result, instead of obtaining a single value as the prediction for the response variable,
the ensemble model produces a full distribution that takes into account the uncertainty in
model parameters. More precisely, for a new input x∗ (not present in D), the ensemble
model F provides the probability that the response is y, when trained with data D (i.e. the
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full predictive posterior distribution):
p(y|x∗,D) =
∫
p(y|x∗,θ)p(θ|D)dθ =
∫
N (y;wT f , σ2)p(θ|D)dθ. (2)
where p(y|x∗,θ) is the predictive distribution of y given input x∗ and model parameters θ,
p(θ|D) is the posterior distribution of model parameters given data D, and f ≡ f(x∗) for
the sake of clarity. Please note that although we have modeled p(y|x∗,θ) to be Gaussian
(equation 1), p(y|x∗,D) is not Gaussian due to the complexity of p(θ|D) arising from the
data and other constraints.
Optimization: suggesting next steps
The optimization phase leverages the predictive model described in the previous section to
find inputs that are predicted to bring us closer to our objective (i.e. maximize or minimize
response, or achieve a desired response level). In mathematical terms, we are looking for a
set of S suggested inputs xs ∈ X ; s = 1, . . . , S, that optimize the response with respect to
the desired objective. Specifically, we want a process that:
i) optimizes the predicted levels of the response variable;
ii) can explore the regions of input phase space associated with high uncertainty in pre-
dicting response, if desired;
iii) provides a set of different recommendations, rather than only one.
These three requirements are met by solving the following optimization problem:
arg max
x
G(x)
s.t. x ∈ B
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where the surrogate function G(x) is defined as:
G(x) =

(1− α)E(y) + αVar(y)1/2 (maximization case)
−(1− α)E(y) + αVar(y)1/2 (minimization case)
−(1− α)||E(y)− y∗||22 + αVar(y)1/2 (specification case)
(3)
depending on which mode ART is operating (see Key capabilities section). Here, y∗ is the
target value for the response variable, y = y(x), E(y) and Var(y) denote the expected value
and variance respectively (see "Expected value and variance for ensemble model" in supp.
material), ||x||22 =
∑
i x
2
i denotes Euclidean distance, and the parameter α ∈ [0, 1] represents
the exploitation-exploration trade-off (see below). The constraint x ∈ B characterizes the
lower and upper bounds for each input feature (e.g. protein levels cannot increase beyond
a given, physical, limit). These bounds can be provided by the user (see details in the
"Implementation" section in the supp. material); otherwise default values are computed
from the input data as described in the "Input space set B" section in the supplementary
material.
Requirements i) and ii) are both addressed by borrowing an idea from Bayesian optimiza-
tion: optimization of a parametrized surrogate function which accounts for both exploitation
and exploration. Namely, our objective function G(x) takes the form of the upper confi-
dence bound54 given in terms of a weighted sum of the expected value and the variance of
the response (parametrized by α, Eq. (3)). This scheme accounts for both exploitation and
exploration: for the maximization case, for example, for α = 1 we get G(x) = Var(y)1/2, so
the algorithm suggests next steps that maximize the response variance, thus exploring parts
of the phase space where our model shows high predictive uncertainty. For α = 0, we get
G(x) = E(y), and the algorithm suggests next steps that maximize the expected response,
thus exploiting our model to obtain the best response. Intermediate values of α produce
a mix of both behaviors. We recommend setting α to values slightly smaller than one for
early-stage DBTL cycles, thus allowing for more systematic exploration of the space so as
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to build a more accurate predictive model in the subsequent DBTL cycles. If the objective
is purely to optimize the response, we recommend setting α = 0.
Figure 3: ART chooses recommendations for next steps by sampling the modes
of a surrogate function. The leftmost figure shows the true response F (x) (e.g. biofuel
production to be optimized) as a function of the input features x (e.g. proteomics data),
as well as the predicted response after several DBTL cycles (green) and its variance (blue).
Depending on whether we prefer to explore the phase space where the model is least accurate
or exploit the predictive model to focus on the highest predicted responses, we will seek to
optimize a surrogate function G(x) (equation 3) where the exploitation-exploration parame-
ter α = 0 (exploitation), α = 1 (exploration) or anything in between. Monte Carlo sampling
in combination with Parallel Tempering (right hand side of figure) produces sets of vectors
x that start sampling the full space (low temperatures, blue) and slowly progress towards
concentrating on the nodes (high temperatures, red). Final recommendations (arrows) to
improve response are provided from these low temperature samples, and chosen such that
they are not too close to each other (at least 20% difference).
In order to address (iii), as well as to avoid entrapment in local optima and search the
phase space more effectively, we choose to solve the optimization problem through sampling.
More specifically, we draw samples from a target distribution defined as
pi(x) ∝ exp(G(x))p(x), (4)
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where p(x) = U(B) can be interpreted as the uniform ‘prior’ on the set B, and exp(G(x))
as the ‘likelihood’ term of the target distribution. Sampling from pi implies optimization of
the function G (but not reversely), since the modes of the distribution pi correspond to the
optima of G. As we did in the previous section, we resort to Markov chain Monte Carlo for
sampling. The target distribution is not necessarily differentiable and may well be complex.
For example, if it displays more than one mode, as is often the case in practice, there is a
risk that a Markov chain gets trapped in one of them. In order to make the chain explore all
areas of high probability one can “flatten/melt down” the roughness of the distribution by
tempering. For this purpose, we use the Parallel Tempering algorithm55 for optimization of
the objective function through sampling, in which multiple chains at different temperatures
are used for exploration of the target distribution.
Choosing recommendations for the next cycle
After drawing a certain number of samples from pi(x) we need to chose recommendations
for the next cycle, making sure that they are sufficiently different from each other as well as
from the input data. To do so, first we find a sample with optimal G(x) (note that G(x)
values are already calculated and stored). We only accept this sample as a recommendation if
there is at least one feature whose value is different by at least a factor γ (e.g. 20% difference,
γ = 0.2) from the values of that feature in all data points x˜ ∈ D. Otherwise, we find the next
optimal sample and check the same condition. This procedure is repeated until the desired
number of recommendations are collected, and the condition involving γ is satisfied for all
previously collected recommendations and all data points. In case all draws are exhausted
without collecting the sufficient number of recommendations, we decrease the factor γ and
repeat the procedure from the beginning. Pseudo code for this algorithm can be found in
the "Pseudo algorithm for recommendations" section in the supplementary material. The
probability of success for these recommendations is computed as indicated in the "Success
probability calculation" section in the supplementary material.
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Implementation
ART is implemented Python 3.6 and should be used under this version. The source code
can be downloaded from https://github.com/JBEI/AutomatedRecommendationTool and
installed by the command python setup.py install. Figure S1 represents the main code
structure and its dependencies to external packages. In the "Implementation" section of the
supp. material, we provide explanations of the main modules and functions.
Results and discussion
Using simulated data to test ART
Synthetic data sets allow us to test how ART performs when confronted by problems of
different difficulty and dimensionality, as well as gauge the effect of the availability of more
training data. In this case, we tested the performance of ART for 1–10 DBTL cycles, three
problems of increasing difficulty (FE, FM and FD, see Table 1) and three different dimensions
of input space (D = 2, 10 and 50), as shown in Fig. 4. We simulated the DBTL processes by
starting with a training set given by 16 strains and measurements in triplicates (mimicking
the 48 wells of throughput of a typical automated fermentation platform56). We limited
ourselves to the maximization case, and at each DBTL cycle generated 16 recommendations
that maximize the objective function given by Eq. (3). We employ a tempering strategy for
the exploitation-exploration parameter, i.e. assign α = 1 at start for a purely exploratory
optimization, and gradually decrease the value to α = 0 in the final DBTL cycle for the
exploitative maximization of the production levels.
ART performance improves significantly as more DTBL cycles are added. Whereas the
prediction error, given in terms of Mean Average Error (MAE) remains constantly low for the
training set (i.e. ART is always able to reliably predict data it has already seen), the MAE for
the test data (data ART has not seen) in general decreases markedly only with the addition
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Table 1: Functions presenting different levels of difficulty to being learnt, used to produce
synthetic data and test ART’s performance.
Easy
FE(x) =
−1
d
∑d
i (xi − 5)2 + exp (−
∑
i x
2
i ) + 25
Medium
FM(x) =
1
d
∑d
i (x
4
i − 16x2i + 5xi)
Difficult
FD(x) =∑d
i
√
xi sin(xi)
of more DBTL cycles. The exception are the most complicated problems: those exhibiting
highest dimensionality (D = 50), where MAE stays approximately constant, and the difficult
function FD, which exhibits a slower decrease. Furthermore, the best production obtained
in the simulated process, given in terms of the highest mean predicted production, increases
monotonically with more DBTL cycles: faster for easier problems and lower dimensions and
more slowly for harder problems and higher dimensions. Finally, the uncertainty in those
predictions decreases as more DBTL cycles proceed. Hence, more data (DBTL cycles) almost
always translates into better predictions and production. However, we see that these benefits
are rarely reaped with only the 2 DBTL cycles customarily used in metabolic engineering
(see examples in the next sections): ART (and ML in general) becomes only truly efficient
when using 5–10 DBTL cycles.
Different problems present different difficulties to being learnt (i.e. being predicted accu-
rately), and this can only be assessed empirically. Low dimensional problems can be easily
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Figure 4: ART performance improves significantly by proceeding beyond the usual
two Design-Build-Test-Learn cycles. Here we show the results of testing ART’s per-
formance with synthetic data obtained from functions of different levels of complexity (see
Table 1), different phase space dimensions (2, 10 and 50), and different amounts of training
data (DBTL cycles). The leftmost column presents the Medium Average Error (MAE) in
production predictions, which decreases drastically as more data (DBTL cycles) are added,
with the exception of the high dimension case. The center column presents the results of
the simulated metabolic engineering in terms of highest production achieved so far. The
production increases monotonically with a rate that decreases as the problem is harder to
learn and the dimensionality increases. The right column shows the uncertainty in ART’s
production prediction, which decreases markedly with the number of DBTL cycles except
for the highest number of dimensions.
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learnt, whereas exploring and learning a 50 dimensions landscape is very slow (Fig. 4). Dif-
ficult problems (i.e. less monotonic landscapes) take more data to learn and traverse than
easier ones. We will see this effect in terms of real experimental data when comparing the
biofuel project (easy) versus the dodecanol project (hard) below. However, it is not possible
to decide a priori whether a given real data project or problem will be easy or hard to learn:
the only way to determine this is by checking the change in prediction accuracy as more data
is added.
Improving the production of renewable biofuel
The optimization of the production of the renewable biofuel limonene through synthetic
biology will be our first demonstration of ART using real-life experimental data. Renewable
biofuels are almost carbon neutral because they only release into the atmosphere the carbon
dioxide that was taken up in growing the plant biomass they are produced from. Biofuels
from renewable biomass have been estimated to be able to displace ∼30% of petroleum
consumption57 and are seen as the most viable option for decarbonizing sectors that are
challenging to electrify, such as heavy-duty freight and aviation.58
Limonene is a molecule that can be chemically converted to several pharmaceutical and
commodity chemicals.59 If hydrogenated, for example, it has low freezing point and is im-
miscible with water, characteristics which are ideal for next generation jet-biofuels and fuel
additives that enhance cold weather performance.60,61 Limonene has been traditionally ob-
tained from plant biomass, as a byproduct of orange juice production, but fluctuations in
availability, scale and cost limit its use as biofuel.62 The insertion of the plant genes respon-
sible for the synthesis of limonene in a host organism (e.g. a bacteria), however, offers a
scalable and cheaper alternative through synthetic biology. Limonene has been produced in
E. coli through an expansion of the celebrated mevalonate pathway,63 used to produce the
antimalarial precursor artemisinin64 and the biofuel farnesene,65 and which forms the tech-
nological base on which the company Amyris was founded (valued ∼$300M ca. 2019). This
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version of the mevalonate pathway is composed of seven genes obtained from such different
organisms as S. cerevesiae, S. aureus, and E. coli, to which two genes have been added: a
geranyl-diphosphate synthase and a limonene synthase obtained from the plants A. grandis
and M. spicata.
For this demonstration, we use historical data from Alonso-Gutierrez et al. 66 , where 27
different variants of the pathway (using different promoters, induction times and induction
strengths) were built. Data collected for each variant involved limonene production and
protein expression for each of the nine proteins involved in the synthetic pathway. These
data were used to feed Principal Component Analysis of Proteomics (PCAP),66 an algorithm
using principal component analysis to suggest new pathway designs. The PCAP recommen-
dations, used to engineer new strains, resulted in a 40% increase in production for limonene,
and 200% for bisabolene (a molecule obtained from the same base pathway). This small
amount of conditions (i.e. data rows) available to train the algorithms is typical of synthetic
biology/metabolic engineering projects. Although we expect automation to change the pic-
ture in the future,25 the lack of large amounts of data has determined the machine learning
approach in ART (i.e. no deep neural networks).
ART is able to not only recapitulate the successful predictions obtained by PCAP im-
proving limonene production, but also provides a systematic way to obtain them as well as
the corresponding uncertainty quantification. In this case, the inputs for training ART are
the concentrations for each of the nine proteins in the heterologous pathway (features), and
the production of limonene (response). The objective is to maximize limonene production.
We have data for two DBTL cycles, and we use ART to explore what would have happened
if we have used ART instead of PCAP for this project.
We used the data from DBLT cycle 1 to test the predictions provided for ART and
suggest new strain designs (i.e. proteomics profiles for the pathway genes). The model
trained with the initial 27 conditions provided reasonable cross-validated predictions for
production (R2 = 0.37) of this set, as well as the three strains which were created for
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Figure 5: Improving renewable biofuel (limonene) production through ART. We
used the first DBTL cycle data (27 strains) to train ART and recommend new protein
targets. The ART recommendations were very similar to the protein concentrations that
eventually led to a 40% increase in production (Fig. 6), and the model predicts production
levels which are very close to the measured ones in the second DBTL cycle (three blue points
in the upper graph). Adding those three points from DBTL cycle 2 provides a total of 30
strains for training that lead to recommendations predicted to exhibit even higher production
(bottom part of the graph).
DBTL cycle 2 at the behest of PCAP (Fig. 5). This suggests that ART would have easily
recapitulated the PCAP results. Indeed, the ART recommendations are very close to the
PCAP recommendations, as shown in Fig. 6. Moreover, the ART recommendations are
predicted to exhibit higher production than the PCAP recommendations. While we cannot
experimentally test this, ART’s capability to predict the result of the PCAP results suggest
ART’s results would have improved upon those of PCAP. Interestingly, we see that while
the quantitative predictions of each of the individual models were not very accurate, they
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all signaled towards the same direction in order to improve production, hence showing the
importance of the ensemble approach (Fig. 6).
Training ART with experimental results from DBTL cycles 1 and 2 results in even better
predictions (R2 = 0.60), highlighting the importance of the availability of large amounts of
data to train ML models. This new model suggests new sets of strains predicted to produce
even higher amounts of limonene.
Brewing hop flavoured beer without hops by engineering specific
levels of production of linalool and geraniol
Our second example involves using the metabolic engineering of yeast (S. cerevisiae) to
produce hoppy beer without the need for hops. To this end, the ethanol-producing yeast used
to brew the beer was modified to also synthesize the metabolites (linalool, L and geraniol,
G) that impart hoppy flavor.67 Synthesizing linalool and geraniol through synthetic biology
is economically advantageous because growing hops is water and energetically intensive, and
their taste is very variable from crop to crop. Indeed, a startup (Berkeley Brewing Science68)
was generated from this technology.
ART is able to reproduce the same type of predictions that required correlation analyses
and three different types of mathematical models in the original publication, providing a
systematic approach to beer flavor design. The challenge is different in this case as compared
to the previous case (limonene): instead of trying to maximize production, the goal is to
reach a particular level of linalool and geraniol so as to match a known beer tasting profile
(e.g. Hop Hunter, Pale Ale, Torpedo or Tropical IPA, Fig. 7). ART can provide this type
of recommendations, as well. For this case, the inputs are the levels for the four different
proteins involved in the pathway, and the output are the concentrations of the two target
molecules (L and G), for which we have desired targets. We have data for two DBTL cycles
involving 50 different strains (19 strains for the first DBTL cycle and 31 for the second one,
Fig. 7). As in the previous case, we use this data to simulate the outcomes we would have
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Figure 6: All machine learning algorithms point in the same direction to improve
limonene production, in spite of quantitative differences in prediction. The color
heatmap indicates the limonene production predicted for each point in the proteomics phase
space for a Random Forest, a Neural Regressor, TPOT and the final ensemble model that
leverages all the models and conforms the base algorithm used by ART. Although the models
differ significantly in the actual quantitative predictions of production, the same qualitative
trends can be seen in all models (i.e. explore upper left quadrant for higher production),
justifying the ensemble approach followed by ART. The ART recommendations (light green)
are very close to the PCAP recommendations (blue) that were experimentally tested to
improve production by 40%.
obtained in case ART had been available for this project.
The first DBTL cycle provides a limited number of 19 strains to train the model, which
performs very well on this training set but poorly on the test set provided by the 31 strains
from DBTL cycle 2 (Fig. 7). Despite this small amount of training data and the poor
performance on test data, the model trained in DBTL cycle 1 is able to recommend new
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protein profiles that are predicted to reach the Pale Ale target (Fig. 7), which are very close
to the protein profiles that were eventually used to meet the target. Similarly, this DBTL
cycle 1 model was almost able to reach (in predictions) the L & G levels for the Torpedo
beer, which will be finally achieved in DBTL cycle 2, once more training data is available.
For the Tropical IPA or Hop Hunter, recommendations from this model were not close to
the target.
Figure 7: Using ART to engineer yeast to produce hoppy beer without the need
for hops. The 19 strains in the first DBTL cycles were used to train ART, but it did
not show an impressive predictive power. In spite of it, ART is still able to recommend
protein profiles predicted to reach the Pale Ale target flavor profile, and others which were
close to the Torpedo profile. Adding the 31 strains for the second DBTL cycle allows us to
recommend profiles which are predicted to reach targets for all beers except Hop Hunter,
which displays a very different metabolite profile from all others.
The model for the second DBTL cycle leverages the full 50 strains from cycles 1 and 2 for
training and, although its accuracy is lower, it is enough to provide recommendations that
are predicted to attain three out of four targets. The Pale Ale target was already matched in
the first cycle and the new recommendations maintain the same profile. The Torpedo target
was almost achieved in the first cycle and is predicted to be reached in the second cycle.
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The Tropical IPA cycle 1 recommendations were off target, but the cycle 2 recommendations
are predicted to reach the desired target. Finally, Hop Hunter L&G levels are very different
form all other beers and cycle 1 results, so neither cycle 1 or 2 recommendations can predict
protein profiles achieving this profile. ART has not seen any scenarios with such high levels
of L&G, and cannot extrapolate well into that part of the metabolic phase space.
Improving dodecanol production
The final example is one of a failure (or at least a mitigated success), from which as much can
be learnt as from the previous successes. Opgenorth et al. 69 used machine learning to drive
two DBTL cycles to improve production of 1-dodecanol, a medium-chain fatty acid used in
detergents, emulsifiers, lubricants and cosmetics. Although a 20% increase in production
was achieved, several shortcomings in this general approach (mapping proteomics data to
production) to leverage machine learning to guide metabolic engineering were evidenced:
the machine learning algorithms were not able to produce accurate predictions with the low
amount of data available for training, and the tools available to reach the desired target
protein levels were not accurate enough.
This project consisted of two DBTL cycles comprising 36 and 24 strains, respectively,
for three different pathways. The goal was to modulate the protein expression by choosing
Ribosome Binding Sites (RBSs, the mRNA sites to which ribosomes bind in order to translate
proteins) of different strenghts, and test two alternative routes to the final product. The idea
was for the machine learning to operate on a small number of variables (∼3 RBSs) that, at
the same time, provided significant control over the pathway. The input for ART consisted
of the concentrations for each of three proteins (different for each of the three pathways),
and the goal was to maximize 1-dodecanol production.
The first challenge involved the limited predictive power of the machine learning model
in this project. As shown in Fig. 8 for one of the pathways, ART prediction accuracy is
completely compromised in this example. The causes seem to be double: a small training
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set and a strong connection of the pathway to the rest of host metabolism. The initial 36
strains were divided into three different designs (pathways), decimating the predictive power
of ART. This claim is supported by the S5 figure in Opgenorth et al. 69 , which shows the
predictive error decreasing with the amount of strains/designs. Now, it is complicated to
estimate the number of strains needed for accurate predictions because that depends on the
complexity of the problem to be learnt (see synthetic data set section). In this case, the
problem is harder to learn than the previous two examples: the mevalonate pathway used in
these examples is fully exogenous (i.e. built from external genetic parts) to the final yeast
host and hence, free of the metabolic regulation that is certainly present for the dodecanol
producing pathway. The dodecanol pathway depends on fatty acid biosynthesis which is vital
for cell survival (it produces the cell membrane), and has to be therefore tightly regulated.
This characteristic makes it more difficult to learn its behavior by ART using only pathway
protein levels (instead of adding also proteins from other parts of host metabolism).
A second challenge compounding the first one involves being unable to reach the target
protein levels proposed by ART to increase production. This difficulty precludes not only
bioengineering, but also testing the validity of the ART model. For this case, both the
mechanistic (RBS calculator70,71) and machine learning-based (EMOPEC72) tools proved to
be very inaccurate for bioengineering purposes: e.g. a prescribed 6-fold increase in protein
expression could only be matched with a 2-fold increase. Moreover, non-target effects (i.e.
changing the RBS for a gene significantly affects protein expression for other genes in the
pathway) were abundant, further adding to the difficulty.
A third, unexpected, challenge was the inability of constructing several strains in the
Build phase due to toxic effects engendered by the proposed protein profiles. This phe-
nonenon materialized through mutations in the final plasmid in the production strain or no
colonies after the transformation. The prediction of these effects in the Build phase rep-
resents an important target for future ML efforts, with the capability to not only enhance
bioengineering but reveal fundamental biological knowledge.
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Figure 8: Leveraging ART to improve dodecanol production. The scarce amount
of initial data (12 strains) plus the strong tie of the pathway to metabolism (fatty acids)
produce a model that is scarcely predictive (top of the graph). Adding data from both cycles
(1 and 2) improves predictions notably (bottom graph).
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In spite of all these challenges, the ML-based approach was able to improve production
with respect to the first cycle by ∼20%,69 6-fold higher than the best published titer for the
same fermentation conditions.73 While this ∼20% was not transformational, one can imagine
systematically applying this approach in several DBTL cycles and, if comparable increases
are obtained, obtaining gains of ∼ 250% in 5 DBTL cycles or ∼ 620% in 10 cycles.
Conclusion
ART is a tool that provides synthetic biologists easy access to machine learning techniques.
ART takes as input a set of vectors of measurements (e.g. a set of proteomics measurements
for several proteins, or transcripts for several genes) along with their corresponding sys-
tems responses (e.g. associated biofuel production) and provides a predictive model, as well
as recommendations for the next round (e.g. new proteomics targets predicted to improve
production in the next round).
ART combines the scikit-learn library with Bayesian inference and MCMC sampling, and
is optimized for the conditions encountered in metabolic engineering: small sample sizes,
recursive DBTL cycles and the need for uncertainty quantification. ART uses a novel ensem-
ble approach where the weight of each ensemble model is considered a random variable with
a probability distribution constrained by the available data. Unlike other approaches, this
method does not require the ensemble models to be probabilistic in nature, hence allowing us
to fully exploit the popular scikit-learn library to increase accuracy by leveraging a diverse
set of models. This weighted ensemble model produces a simple, yet powerful, approach to
quantify uncertainty, a critical capability when dealing with small data sets and a crucial
component of AI in biological research.48 While ART is adapted to synthetic biology’s special
needs and characteristics, its implementation is general enough that it is easily applicable
to other problems of similar chracteristics. ART is perfectly integrated with the Experiment
Data Depot40 and the Inventory of Composable Elements,74 forming part of a growing family
of tools that standardize and facilitate synthetic biology.
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We have showcased the use of ART on a case with synthetic data sets and three real
metabolic engineering cases from the published literature. The synthetic data case involves
data generated for several production landscapes of increasing complexity and dimensionality.
This case allowed us to test ART for different difficulties of the production landscape to be
learnt by the algorithms, as well as different numbers of DBTL cycles. We have seen that
while easy landscapes provide production increases readily after the first cycle, the most
complicated ones require > 5 cycles to start producing satisfactory results. In all cases,
results improved with the number of DBTL cycles, underlying the importance of designing
experiments that continue for ∼ 10 cycles rather than halting the project if results do not
improve in the first few cycles.
The demonstration cases using real data involve engineering E. coli and S. cerevisiae to
produce the renewable biofuel limonene, synthesize metabolites that produce hoppy flavor in
beer, and generate dodecanol from fatty acid biosynthesis. Although we were able to produce
useful recommendations with as low as 11 (hopless beer) or 27 (limonene) conditions, we also
found situations in which such low amounts of data was insufficient for meaningful predictions
(dodecanol). It is impossible to determine a priori how much data will be necessary for
accurate predictions, since this depends on the difficulty of the relationships to be learnt (e.g.
the amount of coupling between the studied pathway and host metabolism). However, one
thing is clear: two DBTL cycles (which was as much as was available for all these examples)
are rarely sufficient for guaranteed convergence of the learning process. We do find, though,
that accurate quantitative predictions are not required to effectively guide bioengineering:
our ensemble approach can successfully leverage qualitative agreement between the models
in the ensemble to compensate for the lack of accuracy. Among the possible pitfalls in
the current approach is the possibility that recommended target protein profiles cannot be
accurately reached, since the tools to produce specified protein levels are still imperfect.
This area needs further investment in order to accelerate bioengineering and make it more
reliable, hence enabling design to a required specification.
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While ART is a useful tool in guiding bioengineering, it represents just an initial step in
applying machine learning to synthetic biology. Future improvements under consideration
include adding a pathway cost ($) function, enabling categorical/discrete input variables,
the inclusion of classification problems, adding new optimization methods, incorporating
covariance of level-0 models into the ensemble model, and incorporating input space errors
into learners. These may not be the preferred list of improvements for every user, so ART’s
dual license allows for modification by third parties for research purposes, as long as the
modifications are offered to the original repository. Hence, users are encouraged to enhance
it in ways that satisfy their needs. Commercial users must license the software (see https:
//github.com/JBEI/AutomatedRecommendationTool for details).
ART provides effective decision-making in the context of synthetic biology, and facili-
tates the combination of machine learning and automation that can disrupt synthetic bi-
ology.25 Combining ML with recent developments in macroscale lab automation,56,75 mi-
crofluidics21,39,76–78 and cloud labs79 may enable self-driving laboratories,80 which augment
automated experimentation platforms with artificial intelligence to facilitate autonomous
experimentation. We believe that fully leveraging AI and automation can catalyze a similar
step forward in synthetic biology as CRISPR-enabled genetic editing, high-throughput multi-
omics phenotyping, and exponentially growing DNA synthesis capabilities have produced in
the recent past.
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Supplementary material
Markov Chain Monte Carlo sampling
The posterior distribution p(θ|D) (probability that the parameters θ fit the data D, used in
equation 2) is obtained by applying Bayes’ formula. The posterior is defined through a prior
p(θ) and a likelihood function p(D|θ), i.e.
p(θ|D) ∝ p(D|θ)p(θ).
We define the prior to be p(θ) = p(w)p(σ), where p(w) is a Dirichlet distribution with
uniform parameters, which ensures the constraint on weights is satisfied, and p(σ) is a half
normal distribution with mean = 0 and standard deviation = 10. The likelihood function
follows directly from Eq. (1).
Expected value and variance for ensemble model
From equation (1), we can easily compute the expected value
E(y) = E(wT f + ε) = E(w)T f (5)
and variance
Var(y) = fTVar(w)f + Var(ε) (6)
of the response, which will be needed for the optimization phase in order to create the
surrogate function G(x) (Eq. 3).
Related work and novelty of our ensemble approach.
Our ensemble approach is based on stacking,50 where different ensemble members are trained
on the same training set and whose outputs are then combined, as opposed to techniques
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that manipulate the training set (e.g. bagging81) or those that sequentially add new mod-
els into the ensemble (e.g. boosting82). Different approaches for constructing ensemble of
models using the Bayesian framework have been already considered. For example, Bayesian
Model Averaging (BMA)44 builds an ensemble model as a linear combination of the indi-
vidual members in which the weights are given by the posterior probabilities of models.
The weights therefore crucially depend on marginal likelihood under each model, which is
challenging to compute. BMA accounts for uncertainty about which model is correct but
assumes that only one of them is, and as a consequence, it has the tendency of selecting
the one model that is closest to the generating distribution. Agnostic Bayesian learning of
ensembles83 differs from BMA in the way the weights are calculated. Instead of finding the
best predictor from the model class (assuming that the observed data is generated by one of
them), this method aims to find the best predictor in terms of the lowest expected loss. The
weights are calculated as posterior probability that each model is the one with the lowest
loss. Bayesian model combination (BMC)45 seeks the combination of models that is closest
to the generating distribution by heavily weighting the most probable combination of mod-
els, instead of doing so for the most probable one. BMC samples from the space of possible
ensembles by randomly drawing weights from a Dirichlet distribution with uniform parame-
ters. The Bayesian Additive Regression Trees (BART)47 method is one of the homogeneous
ensemble approaches. It models the ensemble as a (nonweighted) sum of regression trees
whose parameters, and ensemble error standard deviation, are defined thought their poste-
rior distributions given data and sampled using MCMC. Yao et al. 46 suggest a predictive
model in terms of a weighted combination of predictive distributions for each probabilistic
model in the ensemble. This approach can be seen as a generalization of stacking for point
estimation to predictive distributions.
All of these models, except of BMC and our model, have weights being point estimates,
obtained usually by minimizing some error function. In contrast, we define them as random
variables, and in contrast to BMC, our weights are defined through full joint posterior distri-
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bution given data. BMC is the closest in design to our approach, but it was formulated only
in the context of classifiers. Only BART does include a random error term in the ensemble,
apart from our model. Unlike BMA, BMC or models of Yao et al. 46 , Chipman et al. 47 , our
approach does not require that the predictors are themselves probabilistic, and therefore can
readily leverage various scikit-learn models. The main differences are summarized in Table
S1.
Table S1: Feature differences between Bayesian based ensemble modeling approaches.
Method Weighted Probabilistic Probabilistic Regression Classification Ensembleaverage base models weights error term
BMA44 4 4 8 4 4 8
BMC45 4 4 48 8 4 8
BART47 8 4 8 4 8 4
Stacking predictive
4 4 8 4 4 8distributions46
Agnostic Bayes83 4 48 8 4 4 8
This work 4 8 4 4 8 4
Although our model has some features that were previously considered in the literature,
the approach presented here however, to the best of our knowledge, is novel in the fact that
the metalearner is modeled as a Bayesian linear regression model, whose parameters are
inferred from data combined with a prior that satisfies the constraints on the ‘voting’ nature
of ensemble learners.
Input space set B
The bounds for the input space B for G(x) (Eq. 3) can be provided by the user (see details
in the Implementation subsection). Otherwise, default values are computed from the input
34
data defining the feasible space as:
B = {x˜ ∈ RD| Ld −∆d ≤ x˜d ≤ Ud + ∆d , d = 1, . . . , D}
∆d = (Ud − Ld) ; Ud = max
1≤n≤N
(xdn) ; Ld = min
1≤n≤N
(xdn)
(xn, yn) ∈ D, n = 1, . . . , N
(7)
Success probability calculation
Our probabilistic model enables us to quantify uncertainty by systematically estimating
the probability of success for the provided recommendations. Of practical interest are the
probability that a single recommendation is successful, and the probability that at least one
recommendation of several provided is successful.
We define success for response y (in general) through set S = {y|y ∼ pS(y)}, where
probability distribution for success is
pS(y) =

U(y∗, U) (maximization case)
U(L, y∗) (minimization case)
N (y∗, σ2y∗) (specification case),
(8)
with y∗ being a success value defined by the user (e.g. the best production so far improved by
a factor of 20% for the maximization case); L,U the lower and upper bounds, respectively,
for the uniform distribution; and σ2y∗ being the variance of the normal distribution around
the target value y∗ for the specification case. The success probability of interest, i.e. the
posterior probability distribution of success given recommendation xr is then
p(S|xr) =
∫
pS(y)p(y|xr,D)dy
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and is approximated using draws from the posterior predictive distribution (2) as
p(S|xr) ≈

1
Ns
∑Ns
i=1 IS(yi) (maximization/minimization case)
1
Ns
∑Ns
i=1N (yi; y∗, σ2y∗) (specification case)
(9)
where yi ∼ p(y|xr,D), i = 1, . . . , Ns, and IA(y) = 1 if y ∈ A, 0 if y 6∈ A.
In case of multiple recommendations {xr}, we provide the probability of success of least
one of the recommendations only for maximization and minimization types of objectives.
This probability is calculated as one minus the probability p(F|{xr}) that all recommenda-
tions fail, where
p(F|{xr}) ≈ 1
Ns
Ns∑
i=1
IF({yri }), {yri } ∼ p(y|{xr},D), i = 1, . . . , Ns, r = 1, . . . , Nr,
and the failure set F = {{yr}|yr /∈ S,∀r = 1, . . . , Nr} consists of outcomes that are not
successes for all of the recommendations. Since the chosen recommendations are not neces-
sarily independent, we sample {yri } jointly for all {xr}, i.e. i-th sample has the same model
parameters (wi, σi, εij ∼ N (0, σ2i ) from Eq. 1) for all recommendations.
In case of multiple recommendations {xr}, we calculate the probability of success of at
least one of the recommendations as one minus the probability that all recommendations
fail, i.e. 1− p(F|{xr}), where
p(F|{xr}) ≈ 1
Ns
Ns∑
i=1
IF({yri }), {yri } ∼ p(y|{xr},D), i = 1, . . . , Ns, r = 1, . . . , Nr,
and the failure set F = {{yr}|yr /∈ S,∀r = 1, . . . , Nr} consists of outcomes that are not
successes for all of the recommendations. Since the chosen recommendations are not neces-
sarily independent, we sample {yri } jointly for all {xr}, i.e. i-th sample has the same model
parameters (wi, σi, εij ∼ N (0, σ2i ) from Eq. 1) for all recommendations.
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Multiple response variables
For multiple response variable problems (e.g. trying to hit a predetermined value of metabo-
lite a and metabolite b simultaneously, as in the case of the hopless beer), we assume that the
response variables are conditionally independent given input vector x, and build a separate
predictive model pj(yj|x,D) for each variable yj, j = 1, . . . , J . We then define the objective
function for the optimization phase as
G(x) = (1− α)
J∑
j=1
E(yj) + α
J∑
j=1
Var(yj)
1/2
in case of maximization, and analogously adding the summation of expectation and variance
terms in the corresponding functions for minimization and specification objectives (Eq. 3).
The probability of success for multiple variables is then defined as
p(S1, . . . ,SJ |x) =
J∏
j=1
p(Sj|xr)
Future work will address the limitation of the independence assumption and take into
account possible correlations among multiple response variables.
Pseudo algorithm for recommendations
Implementation
Modules
art.py is the core module that defines the class RecommendationEngine with functions for
loading data (into the format required for machine learning models), building predictive
models and optimization.
Module constants.py contains assignments to all constants appearing throughout other
modules. Those include default values for some of the optional user input parameters (Ta-
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Algorithm 1
1: Input: Nr: number of recommendations
Input: {xn}Nsn=1: samples from pi(x)
Input: Ea: engineering accuracy
Input: Dx: input variable experimental data
Input: type of the distance between recommendations
2: Output: XXXXX
3: draws← {xn}Nsn=1 {remaining draws}
4: rec = ∅
5: while i = 1, . . . , Nr do
6: r ← a sample from draws with maximal F (x) {F (x) is already calculated}
7: if check the condition***** then
8: rec = {rec, r}
9: end if
10: draws← draws \ set of all draws with the same F (x)
11: end while
12: return rec
ble S3), hyperparameters for scikit-learn models and simulation setups for PyMC3 and
PTMCMCSampler functions.
Module utilities.py is a suite of functions that facilitate ART’s computations but can
be used independently. It includes functions for loading studies (with edd-utils or directly
from files), metrics for evaluation of predictive models, identifying and filtering noisy data,
etc.
Module plot.py contains a set of functions for visualization of different quantities ob-
tained during an ART run, including functions of relevance to final users (e.g. true vs.
predicted values) as well as those providing insights into intermediate steps (e.g. predictive
models surfaces, space exploration from optimization, recommendations distributions).
All modules can be easily further extended by future contributors to ART.
Importing a study
Studies can be loaded directly from EDD by calling a function from the utility.py module
that relies on edd-utils package:
dataframe = load_study(edd_study_slug=edd_study_slug,edd_server=edd_server)
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Figure S1: The main ART source code structure and dependencies.
The user should provide the study slug (last part of the study web address) and, if
the study is not located on the default (public) EDD server, the url to the EDD server.
Alternatively, a study can be loaded from an EDD-style csv file, by providing a path to the
file and calling the same function
dataframe = load_study(data_file=data_file
Either approach will return a pandas dataframe containing all information in the study,
which can be pre-processed before running ART, if needed.
Running ART
ART can be run by instantiating an object from the RecommendationEngine class by:
art = RecommendationEngine(dataframe, **art_params)
The first argument is the dataframe created in the previous step (from an EDD study
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or data file import). If there is no data preprocessing, the dataframe is ready to be passed
as an argument. Otherwise, the user should make sure that the dataframe contains at least
the required columns: Line Name, Measurement Type and Value. Furthermore, line names
should always contain a hyphen (“-”) denoting replicates (see Table S2), and this character
should be exclusively used for this purpose (this is critical for creating partitions for cross-
validation).
Table S2: Valid and non valid examples of entries of the Line Name column in the dataframe
passed to start an ART run.
4 Valid 8 Non valid
LineNameX-1 LineNameX1
LineNameX-2 LineNameX2
LineNameX-r1 Line-NameX1
LineNameX-r2 Line-NameX2
LineNameX-R1 Line-Name-X1
LineNameX-R2 Line-Name-X2
. . . . . .
The second argument is a dictionary of key-value pairs defining several required and
optional keyword arguments (summarized in Table S3) for generation of the art object.
Building the model
The level-0 models are first initialized and then fitted through the _initialize_models
and _fit_models functions respectively, which rely on the scikit-learn and tpot packages.
To build the final predictive model, first the level-1 data is created by storing cross-validated
predictions of level-0 models into a theano variable that is shared across the functions from
the PyMC3 package. Finally, the parameters of the ensemble model are sampled within the
function _ensemble_model, which stores the inferred model and traces that are later used
for predictive posterior probability calculation, as well as first and second moments from the
traces, used for estimation of the first two moments of the predictive posterior distribution
using Eq. (5)–(6).
By default, ART builds the models using all available data and evaluates the final, ensem-
ble model, as well as all level-0 models, on the same data. Optionally, if specified by the user
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Table S3: ART input parameters. Required parameters are marked with an asterisk.
Name Meaning
input_var List of input variables*
bounds_file Path to the file with upper and lower bounds for each input variable
(default None)
response_var List of response variables*
build_model Flag for building a predictive model (default True)
cross_val Flag for performing cross-validation (default False)
ensemble_model Type of the ensemble model (default ‘BW’)
num_models Number of level-0 models (default 8)
recommend Flag for performing optimization and providing recommendations
(default True)
objective Type of the objective (default ‘maximize’)
threshold Relative threshold for defining success (default 0)
target_value Target value for the specification objective (default None)
num_recommendations Number of recommendations for the next cycle (default 16)
rel_eng_accuracy Relative engineering accuracy or required relative distance between
recommendations (default 0.2)
niter Number of iterations to use for T = 1 chain in parallel tempering
(default 100000)
alpha Parameter determining the level of exploration during the
optimization (value between 0 and 1, default None)
output_directory Path of the output directory (default
../results/response_var_time_suffix)
verbose Amount of information displayed (default 0)
seed Random seed for reproducible runs (default None)
through the input flag cross_val, ART will evaluate the models on 10-fold cross-validated
predictions, through the function _cross_val_models. This computation lasts roughly 10
times longer. Evaluating models on new data, unseen by the models, can also be done by
calling:
art.evaluate_models(X=X_new, y=y_new)
Optimization
ART performs optimization by first creating a set of draws from
draws = art.parallel_tempering_opt()
which relies on the PTMCMCSampler package. Here, an object from the class TargetModel
is being created. This class provides a template for and can be replaced by other types of ob-
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jective functions (or target distributions) for parallel tempering type of optimization, as long
as it contains functions defining loglikelihood and logprior calculation (see Eq. 4). Also, the
whole optimization procedure may well be replaced by an alternative routine. For example,
if the dimension of the input space is relatively small, a grid search could be performed, or
even evaluation of the objective at each point for discrete variables. Lastly, out of all draws
collected by optimizing the specified objective, ART finds a set of recommendations by
art.recommend(draws, rel_eng_accuracy=rel_eng_accuracy, distance_type=’at_least_one’)
which ensures that each recommendation is different from all others and all input data by a
factor of rel_eng_accuracy (γ) in at least one of the components.
Figure S2: Dodecanol Pathway 2
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Figure S3: Dodecanol Pathway 3
43
References
(1) Stephanopoulos, G. Metabolic fluxes and metabolic engineering. Metabolic engineering
1999, 1, 1–11.
(2) Beller, H. R.; Lee, T. S.; Katz, L. Natural products as biofuels and bio-based chemicals:
fatty acids and isoprenoids. Natural product reports 2015, 32, 1508–1526.
(3) Chubukov, V.; Mukhopadhyay, A.; Petzold, C. J.; Keasling, J. D.; Martín, H. G. Syn-
thetic and systems biology for microbial production of commodity chemicals. npj Sys-
tems Biology and Applications 2016, 2, 16009.
(4) Ajikumar, P. K.; Xiao, W.-H.; Tyo, K. E.; Wang, Y.; Simeon, F.; Leonard, E.;
Mucha, O.; Phon, T. H.; Pfeifer, B.; Stephanopoulos, G. Isoprenoid pathway opti-
mization for Taxol precursor overproduction in Escherichia coli. Science 2010, 330,
70–74.
(5) Cann, O. These are the top 10 emerging technologies of 2016. World Economic Forum
website https://www. weforum. org/agenda/2016/06/top-10-emergingtechnologies-
2016. 2016.
(6) Council, N. R.; ADDAUTHORS, Industrialization of Biology: A Roadmap to Accelerate
the Advanced Manufacturing of Chemicals ; National Academies Press, 2015.
(7) Yadav, V. G.; De Mey, M.; Lim, C. G.; Ajikumar, P. K.; Stephanopoulos, G. The
future of metabolic engineering and synthetic biology: towards a systematic practice.
Metabolic engineering 2012, 14, 233–241.
(8) Hodgman, C. E.; Jewett, M. C. Cell-free synthetic biology: thinking outside the cell.
Metabolic engineering 2012, 14, 261–269.
(9) Kurian, J. V. A new polymer platform for the futureâĂŤSorona R© from corn derived
1, 3-propanediol. Journal of Polymers and the Environment 2005, 13, 159–167.
44
(10) Cameron, D. E.; Bashor, C. J.; Collins, J. J. A brief history of synthetic biology. Nature
Reviews Microbiology 2014, 12, 381.
(11) Kyrou, K.; Hammond, A. M.; Galizi, R.; Kranjc, N.; Burt, A.; Beaghton, A. K.;
Nolan, T.; Crisanti, A. A CRISPR–Cas9 gene drive targeting doublesex causes complete
population suppression in caged Anopheles gambiae mosquitoes. Nature biotechnology
2018, 36, 1062.
(12) Temme, K.; Tamsir, A.; Bloch, S.; Clark, R.; Emily, T.; Hammill, K.; Higgins, D.;
Davis-Richardson, A. Methods and compositions for improving plant traits. 2019; US
Patent App. 16/192,738.
(13) Chen, Y.; Guenther, J. M.; Gin, J. W.; Chan, L. J. G.; Costello, Z.; Ogorzalek, T. L.;
Tran, H. M.; Blake-Hedges, J. M.; Keasling, J. D.; Adams, P. D.; Garcia Martin, H.;
Hillson, N. J.; Petzold, C. J. Automated “Cells-To-Peptides” Sample Preparation Work-
flow for High-Throughput, Quantitative Proteomic Assays of Microbes. Journal of pro-
teome research 2019, 18, 3752–3761.
(14) Fuhrer, T.; Zamboni, N. High-throughput discovery metabolomics. Current opinion in
biotechnology 2015, 31, 73–78.
(15) Stephens, Z. D.; Lee, S. Y.; Faghri, F.; Campbell, R. H.; Zhai, C.; Efron, M. J.; Iyer, R.;
Schatz, M. C.; Sinha, S.; Robinson, G. E. Big data: astronomical or genomical? PLoS
biology 2015, 13, e1002195.
(16) Ma, S.; Tang, N.; Tian, J. DNA synthesis, assembly and applications in synthetic
biology. Current opinion in chemical biology 2012, 16, 260–267.
(17) Doudna, J. A.; Charpentier, E. The new frontier of genome engineering with CRISPR-
Cas9. Science 2014, 346, 1258096.
45
(18) Cumbers, J. Synthetic Biology Has Raised $12.4 Billion. Here Are Five Sectors It Will
Soon Disrupt. 2019; https://www.forbes.com/sites/johncumbers/2019/09/04/
synthetic-biology-has-raised-124-billion-here-are-five-sectors-it-will-soon-disrupt/
#40b2b2cb3a14.
(19) Petzold, C. J.; Chan, L. J. G.; Nhan, M.; Adams, P. D. Analytics for metabolic engi-
neering. Frontiers in bioengineering and biotechnology 2015, 3, 135.
(20) Nielsen, J.; Keasling, J. D. Engineering cellular metabolism. Cell 2016, 164, 1185–1197.
(21) Gardner, T. S. Synthetic biology: from hype to impact. Trends in biotechnology 2013,
31, 123–125.
(22) Prinz, F.; Schlange, T.; Asadullah, K. Believe it or not: how much can we rely on
published data on potential drug targets? Nature reviews Drug discovery 2011, 10,
712.
(23) Baker, M. 1,500 scientists lift the lid on reproducibility. Nature News 2016, 533, 452.
(24) Begley, C. G.; Ellis, L. M. Drug development: Raise standards for preclinical cancer
research. Nature 2012, 483, 531.
(25) Carbonell, P.; Radivojević, T.; Martin, H. G. Opportunities at the Intersection of
Synthetic Biology, Machine Learning, and Automation. ACS Synth. Biol. 2019, 8,
1474–1477.
(26) Thrun, S. Toward robotic cars. Communications of the ACM 2010, 53, 99–106.
(27) Wu, Y.; Schuster, M.; Chen, Z.; Le, Q. V.; Norouzi, M.; Macherey, W.; Krikun, M.;
Cao, Y.; Gao, Q.; Macherey, K.; ADDAUTHORS, Google’s neural machine translation
system: Bridging the gap between human and machine translation. arXiv preprint
arXiv:1609.08144 2016,
46
(28) Kosinski, M.; Stillwell, D.; Graepel, T. Private traits and attributes are predictable from
digital records of human behavior. Proceedings of the National Academy of Sciences
2013, 110, 5802–5805.
(29) Costello, Z.; Martin, H. G. A machine learning approach to predict metabolic pathway
dynamics from time-series multiomics data. NPJ systems biology and applications 2018,
4, 19.
(30) Jervis, A. J.; Carbonell, P.; Vinaixa, M.; Dunstan, M. S.; Hollywood, K. A.; Robin-
son, C. J.; Rattray, N. J.; Yan, C.; Swainston, N.; Currin, A.; ADDAUTHORS, Ma-
chine learning of designed translational control allows predictive pathway optimization
in Escherichia coli. ACS synthetic biology 2018, 8, 127–136.
(31) Esteva, A.; Kuprel, B.; Novoa, R. A.; Ko, J.; Swetter, S. M.; Blau, H. M.; Thrun, S.
Dermatologist-level classification of skin cancer with deep neural networks. Nature
2017, 542, 115.
(32) Paeng, K.; Hwang, S.; Park, S.; Kim, M. Deep Learning in Medical Image Analysis and
Multimodal Learning for Clinical Decision Support ; Springer, 2017; pp 231–239.
(33) Alipanahi, B.; Delong, A.; Weirauch, M. T.; Frey, B. J. Predicting the sequence speci-
ficities of DNA-and RNA-binding proteins by deep learning. Nature biotechnology 2015,
33, 831.
(34) Shaked, I.; Oberhardt, M. A.; Atias, N.; Sharan, R.; Ruppin, E. Metabolic network
prediction of drug side effects. Cell systems 2016, 2, 209–213.
(35) Yang, J. H.; Wright, S. N.; Hamblin, M.; McCloskey, D.; Alcantar, M. A.; Schrüb-
bers, L.; Lopatkin, A. J.; Satish, S.; Nili, A.; Palsson, B. O.; ADDAUTHORS, A
White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Ac-
tion. Cell 2019, 177, 1649–1661.
47
(36) Metz, C. AI Researchers Are Making More Than $1 Million, Even at a Nonprofit. The
New York Times 2018,
(37) Pedregosa, F.; Varoquaux, G.; Gramfort, A.; Michel, V.; Thirion, B.; Grisel, O.; Blon-
del, M.; Prettenhofer, P.; Weiss, R.; Dubourg, V.; ADDAUTHORS, Scikit-learn: Ma-
chine learning in Python. Journal of machine learning research 2011, 12, 2825–2830.
(38) Batth, T. S.; Singh, P.; Ramakrishnan, V. R.; Sousa, M. M.; Chan, L. J. G.; Tran, H. M.;
Luning, E. G.; Pan, E. H.; Vuu, K. M.; Keasling, J. D.; ADDAUTHORS, A targeted
proteomics toolkit for high-throughput absolute quantification of Escherichia coli pro-
teins. Metabolic engineering 2014, 26, 48–56.
(39) Heinemann, J.; Deng, K.; Shih, S. C.; Gao, J.; Adams, P. D.; Singh, A. K.;
Northen, T. R. On-chip integration of droplet microfluidics and nanostructure-initiator
mass spectrometry for enzyme screening. Lab on a Chip 2017, 17, 323–331.
(40) Morrell, W. C. et al. The Experiment Data Depot: A Web-Based Software Tool for
Biological Experimental Data Storage, Sharing, and Visualization. ACS Synth. Biol.
2017, 6, 2248–2259.
(41) Wolpert, D. The Lack of A Priori Distinctions between Learning Algorithms. Neural
Computation 1996, 8, 1341–1390.
(42) Ho, T. K. Random Decision Forests. Proceedings of 3rd International Conference on
Document Analysis and Recognition 1995,
(43) van der Laan, M.; Polley, E.; Hubbard, A. Super Learner. Statistical Applications in
Genetics and Molecular Biology 2007, 6 .
(44) Hoeting, J. A.; Madigan, D.; Raftery, A. E.; Volinsky, C. T. Bayesian model averaging:
a tutorial. Statistical Science 1999, 14, 382–417.
48
(45) Monteith, K.; Carroll, J. L.; Seppi, K.; Martinez, T. Turning Bayesian model averaging
into Bayesian model combination. The 2011 International Joint Conference on Neural
Networks. 2011.
(46) Yao, Y.; Vehtari, A.; Simpson, D.; Gelman, A. Using Stacking to Average Bayesian
Predictive Distributions (with Discussion). Bayesian Analysis 2018, 13, 917–1003.
(47) Chipman, H. A.; George, E. I.; McCulloch, R. E. Bayesian Ensemble Learning. Proceed-
ings of the 19th International Conference on Neural Information Processing Systems.
2006; pp 265–272.
(48) Begoli, E.; Bhattacharya, T.; Kusnezov, D. The need for uncertainty quantification in
machine-assisted medical decision making. Nature Machine Intelligence 2019, 1, 20.
(49) Olson, R. S.; Urbanowicz, R. J.; Andrews, P. C.; Lavender, N. A.; Kidd, L. C.;
Moore, J. H. In Applications of Evolutionary Computation: 19th European Confer-
ence, EvoApplications 2016, Porto, Portugal, March 30–April 1, 2016, Proceedings,
Part I ; Squillero, G., Burelli, P., Eds.; Springer International Publishing, 2016; Chap-
ter Automating Biomedical Data Science Through Tree-Based Pipeline Optimization,
pp 123–137.
(50) Breiman, L. Stacked regressions. Machine Learning 1996, 24, 49–64.
(51) LeDell, E. Scalable Ensemble Learning and Computationally Efficient Variance Esti-
mation. Ph.D. thesis, University of California, Berkeley, 2015.
(52) Aldave, R. Systematic Ensemble Learning and Extensions for Regression. Ph.D. thesis,
Université de Sherbrooke, 2015.
(53) Brooks, S., Gelman, A., Jones, G., Meng, X.-L., Eds. Handbook of Markov Chain Monte
Carlo; CRC press, 2011.
49
(54) Snoek, J.; Larochelle, H.; Adams, R. P. Practical Bayesian Optimization of Machine
Learning Algorithms. NIPS’12 Proceedings of the 25th International Conference on
Neural Information Processing Systems. 2012; pp 2951–2959.
(55) Earl, D. J.; Deem, M. W. Parallel tempering: Theory, applications, and new perspec-
tives. Physical Chemistry Chemical Physics 2005, 7 .
(56) Unthan, S.; Radek, A.; Wiechert, W.; Oldiges, M.; Noack, S. Bioprocess automation
on a Mini Pilot Plant enables fast quantitative microbial phenotyping. Microbial cell
factories 2015, 14, 32.
(57) Langholtz, M.; Stokes, B.; Eaton, L. 2016 Billion-ton report: Advancing domestic
resources for a thriving bioeconomy, Volume 1: Economic availability of feedstock. Oak
Ridge National Laboratory, Oak Ridge, Tennessee, managed by UT-Battelle, LLC for
the US Department of Energy 2016, 2016, 1–411.
(58) Renouard-Vallet, G.; Saballus, M.; Schmithals, G.; Schirmer, J.; Kallo, J.;
Friedrich, K. A. Improving the environmental impact of civil aircraft by fuel cell tech-
nology: concepts and technological progress. Energy & Environmental Science 2010,
3, 1458–1468.
(59) Keasling, J. D. Manufacturing molecules through metabolic engineering. Science 2010,
330, 1355–1358.
(60) Tracy, N. I.; Chen, D.; Crunkleton, D. W.; Price, G. L. Hydrogenated monoterpenes as
diesel fuel additives. Fuel 2009, 88, 2238–2240.
(61) Ryder, J. A. Jet fuel compositions. 2009; US Patent 7,589,243.
(62) Duetz, W.; Bouwmeester, H.; Van Beilen, J.; Witholt, B. Biotransformation of limonene
by bacteria, fungi, yeasts, and plants. Applied microbiology and biotechnology 2003, 61,
269–277.
50
(63) Alonso-Gutierrez, J.; Chan, R.; Batth, T. S.; Adams, P. D.; Keasling, J. D.; Pet-
zold, C. J.; Lee, T. S. Metabolic engineering of Escherichia coli for limonene and perillyl
alcohol production. Metabolic engineering 2013, 19, 33–41.
(64) Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.;
Leavell, M.; Tai, A.; Main, A.; Eng, D.; ADDAUTHORS, High-level semi-synthetic
production of the potent antimalarial artemisinin. Nature 2013, 496, 528.
(65) Meadows, A. L.; Hawkins, K. M.; Tsegaye, Y.; Antipov, E.; Kim, Y.; Raetz, L.;
Dahl, R. H.; Tai, A.; Mahatdejkul-Meadows, T.; Xu, L.; ADDAUTHORS, Rewriting
yeast central carbon metabolism for industrial isoprenoid production. Nature 2016,
537, 694.
(66) Alonso-Gutierrez, J.; Kim, E.-M.; Batth, T. S.; Cho, N.; Hu, Q.; Chan, L. J. G.; Pet-
zold, C. J.; Hillson, N. J.; D.Adams, P.; Keasling, J. D.; Martin, H. G.; SoonLee, T.
Principal component analysis of proteomics (PCAP) as a tool to direct metabolic en-
gineering. Metabolic Engineering 2015, 28, 123–133.
(67) Denby, C. M.; Li, R. A.; Vu, V. T.; Costello, Z.; Lin, W.; Chan, L. J. G.; Williams, J.;
Donaldson, B.; Bamforth, C. W.; Christopher J. Petzold, H. V. S.; Martin, H. G.;
Keasling, J. D. Industrial brewing yeast engineered for the production of primary flavor
determinants in hopped beer. Nature Communications 2018, 9, 965.
(68) https://www.crunchbase.com/organization/berkeley-brewing-science#
section-overview.
(69) Opgenorth, P. et al. Lessons from Two DesignâĂŞBuildâĂŞTestâĂŞLearn Cycles of
Dodecanol Production in Escherichia coli Aided by Machine Learning. ACS Synth.
Biol. 2019, 8, 1337–1351.
(70) Salis, H. M.; Mirsky, E. A.; Voigt, C. A. Automated design of synthetic ribosome
binding sites to control protein expression. Nature biotechnology 2009, 27, 946.
51
(71) Espah Borujeni, A.; Channarasappa, A. S.; Salis, H. M. Translation rate is controlled
by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at
upstream standby sites. Nucleic acids research 2013, 42, 2646–2659.
(72) Bonde, M. T.; Pedersen, M.; Klausen, M. S.; Jensen, S. I.; Wulff, T.; Harrison, S.;
Nielsen, A. T.; Herrgård, M. J.; Sommer, M. O. Predictable tuning of protein expression
in bacteria. Nature methods 2016, 13, 233.
(73) Liu, A.; Tan, X.; Yao, L.; Lu, X. Fatty alcohol production in engineered E. coli express-
ing Marinobacter fatty acyl-CoA reductases. Applied microbiology and biotechnology
2013, 97, 7061–7071.
(74) T.S., H.; Z., D.; H., P.; J., C.; N.J., H.; J.D., K. Design, implementation and practice
of JBEI-ICE: an open source biological part registry platform and tools. Nucleic Acids
Res. 2012, 40 .
(75) Granda, J. M.; Donina, L.; Dragone, V.; Long, D.-L.; Cronin, L. Controlling an organic
synthesis robot with machine learning to search for new reactivity. Nature 2018, 559,
377.
(76) Le, K.; Tan, C.; Gupta, S.; Guhan, T.; Barkhordarian, H.; Lull, J.; Stevens, J.;
Munro, T. A novel mammalian cell line development platform utilizing nanofluidics
and optoelectro positioning technology. Biotechnology progress 2018, 34, 1438–1446.
(77) Iwai, K.; Ando, D.; Kim, P. W.; Gach, P. C.; Raje, M.; Duncomb, T. A.; Heine-
mann, J. V.; Northen, T. R.; Martin, H. G.; Hillson, N. J.; ADDAUTHORS, Automated
flow-based/digital microfluidic platform integrated with onsite electroporation process
for multiplex genetic engineering applications. 2018 IEEE Micro Electro Mechanical
Systems (MEMS). 2018; pp 1229–1232.
(78) Gach, P. C.; Shih, S. C.; Sustarich, J.; Keasling, J. D.; Hillson, N. J.; Adams, P. D.;
52
Singh, A. K. A droplet microfluidic platform for automating genetic engineering. ACS
synthetic biology 2016, 5, 426–433.
(79) Hayden, E. C. The automated lab. Nature News 2014, 516, 131.
(80) Häse, F.; Roch, L. M.; Aspuru-Guzik, A. Next-generation experimentation with self-
driving laboratories. Trends in Chemistry 2019,
(81) Breiman, L. Bagging Predictors. Machine Learning 1996, 24, 123–140.
(82) Freund, Y.; Schapire, R. E. A Decision-Theoretic Generalization of On-Line Learning
and an Application to Boosting. Journal of Computer and System Sciences 1997, 55,
119–139.
(83) Lacoste, A.; Marchand, M.; Laviolette, F.; Larochelle, H. Agnostic Bayesian Learning
of Ensembles. Proceedings of the 31st International Conference on Machine Learning.
2014; pp 611–619.
53
